Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to demonstrate the efficacy of at least 1 dose of tapentadol IR 50 mg and/or 75 mg versus placebo using the sum of pain intensity difference at 48 hours (SPID48) to measure analgesic effect in Korean patients with acute pain following bunionectomy.


Clinical Trial Description

This is a randomized (study drug assigned by chance like flipping a coin), double-blind (neither physician nor patient knows the name of the assigned drug), placebo-controlled, parallel-group, multicenter study to evaluate the efficacy and safety of tapentadol immediate-release (IR) 50 mg and 75 mg in patients who are undergoing bunionectomy (a surgical procedure to remove a bunion). This study was designed to be a similar study to the pivotal global study of PAI-3003/KF32 in order to bridge the results from the global studies and to show similarity in effect of tapentadol between Korean and Caucasian population which will allow extrapolation of the foreign clinical data of tapentadol into Korea. The study will be divided into screening period, surgical period, qualification period, and a double-blind treatment period. The study length, including the screening period, will be up to a maximum duration of 32 days. Eligible patients will be randomly assigned to 1 of 3 treatment groups (tapentadol IR 50 mg, tapentadol IR 75 mg or placebo) in a 1:1:1 ratio. Efficacy and safety assessments will be performed during the study. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01516008
Study type Interventional
Source Janssen Research & Development, LLC
Contact
Status Completed
Phase Phase 3
Start date January 2012
Completion date February 2013

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04473196 - The Effect of Weight Bearing on Patient Outcomes Following 1st MTP Joint Fusion N/A
Recruiting NCT05555459 - Performance and Safety Evaluation of Inion CompressOn Screw in Foot and Ankle Surgeries. PMCF Investigation N/A
Recruiting NCT05587569 - Outcomes Following Combined Adductoplasty™ and Lapiplasty® (MTA3D) N/A
Completed NCT02121119 - Lidocaine Versus Bupivacaine in Ambulatory Continuous Block With Elastomeric Pump Phase 4
Enrolling by invitation NCT00600899 - Home Infusors for Analgesia After Foot Surgery Phase 4
Completed NCT05579054 - Translation, Validity, and Reliability of the Foot Posture Index (FPI-6) - Turkish Version
Terminated NCT05082012 - Early Weight-Bearing After the Lapiplasty Mini-Incision Procedure (Mini3D) N/A
Recruiting NCT05051709 - Can Hypermobility of First Ray Affect Surgical Treatment of Hallux Valgus N/A
Recruiting NCT04716140 - Prospective Study: The Effect on Clinical Outcome After Treatment of MTP Cartilage Lesions in Hallux Valgus Surgery N/A
Active, not recruiting NCT04145882 - Efficacy of Additional Osteotomies to Correct Hallux Valgus N/A
Completed NCT04468555 - Hallux Valgus Manual Therapy Based on Global Postural Reeducation. N/A
Terminated NCT03257540 - Early Weight-Bearing After Lapidus Arthrodesis
Completed NCT03846687 - Validation of Patient Reported Outcome Measures for Use in Hallux Valgus
Completed NCT04365712 - Osteotomy of the 1st Metatarsal for Hallux Valgus Using Pneumatic Oscillating Saw or Piezoelectric Scalpel N/A
Recruiting NCT02282956 - Ultrasound Guided Single Shot Block of Posterior Tibial Nerve for Postoperative Pain Relief After Hallux Valgus Surgery Phase 4
Withdrawn NCT01555216 - Continuous Tibial Nerve Block Versus Single Shot Tibial Nerve Block N/A
Completed NCT00683137 - Analgesic Efficacy And Safety of Valdecoxib For Treatment Of Post-Surgical Pain From Bunionectomy Surgery Phase 3
Terminated NCT04103814 - Effect of Topical CBD Cream for Degenerative Hallux Disorders Phase 2/Phase 3
Completed NCT03423498 - The Toe-spread-out Exercise in Patients With Hallux Valgus and Without the Deformity N/A
Not yet recruiting NCT06076655 - Hallux Valgus Treatment Developed for Children With Cerebral Palsy N/A